CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function

Clinical trial NCT01678794 · COMPLETED

Trial details

NCT number: NCT01678794
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cardiorenal Syndrome (CRS)

Start date: 2012-02-01
Primary completion: 2016-06-29
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.